|
Real-time Estimate
Cboe BZX
13:12:51 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 1.235 USD | +2.92% |
|
-2.38% | -47.21% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 69.88M | - | - | - | - | - |
| 71.53B | |||||
| 60.12B | |||||
| 48.85B | |||||
| 44.28B | |||||
| 43.83B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
